Supplementary Tables 1 from A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

<p>Supplementary TablesSupplementary Table 1: Patient and tumor sample informationSupplementary Table 2: Tumor mutation burdenSupplementary Table 3: Unfiltered whole exome sequencing mutation analysisSupplementary Table 4: Filtered whole exome sequencing mutation analysisSupplementary Table 5:...

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Principal: H. Josh Jang (15206898) (author)
Outros autores: Galen Hostetter (15053070) (author), Alexander W. Macfarlane (15206901) (author), Zachary Madaj (15206904) (author), Eric A. Ross (15019395) (author), Toshinori Hinoue (15206907) (author), Justin R. Kulchycki (15206910) (author), Ryan S. Burgos (15206913) (author), Mahvish Tafseer (15206916) (author), R. Katherine Alpaugh (15206919) (author), Candice L. Schwebel (15206922) (author), Rutika Kokate (15206925) (author), Daniel M. Geynisman (15206928) (author), Matthew R. Zibelman (15206931) (author), Pooja Ghatalia (15206934) (author), Peter W. Nichols (15206937) (author), Woonbok Chung (15206940) (author), Jozef Madzo (14923007) (author), Noah M. Hahn (15206943) (author), David I. Quinn (15012291) (author), Jean-Pierre J. Issa (15109358) (author), Michael J. Topper (15206946) (author), Stephen B. Baylin (15045804) (author), Hui Shen (10996894) (author), Kerry S. Campbell (9724036) (author), Peter A. Jones (14941116) (author), Elizabeth R. Plimack (15044781) (author)
Publicado: 2025
Subjects:
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!